Innovating Care Pathways: From Population Screening to Wraparound Support

In the final episode with Dr. Jhamb, ‘Innovating Care Pathways: From Population Screening to Wraparound Support,’ the panelist explored the following critical questions:

Beyond CKD, how should health systems expand early detection frameworks to other interconnected CRM conditions?

What are the unmet needs in CRM and how can they be addressed?

The expert nephrologist examined the necessity of breaking down traditional clinical silos—such as cardiology, endocrinology, and hepatology—to create resource-efficient, value-based models of care. Manisha Jhamb emphasized the role of multidisciplinary teams, including pharmacists and advanced practice providers (APPs), in delivering scalable care pathways that address both clinical management and social determinants of health, such as food insecurity. The conversation concluded with a vision for the future of cardio-renal-metabolic (CRM) syndrome, highlighting the need for guideline-directed medical therapy (GDMT) algorithms and a transition toward a precision medicine approach driven by genetic and biomarker testing.

Throughout the conversation, the experts provided a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.

Thank you for watching this Insights series with Dr. Jhamb on cardio-renal-metabolic syndrome and be sure to tune into the rest of the episodes with other experts. Please subscribe to our newsletter for information on upcoming video series.